Contact
Please use this form to send email to PR contact of this press release:
Retrophin Receives European Orphan Drug Designation for RE-024 for the Treatment of Pantothenate Kinase-Associated Neurodegeneration
TO:
Please use this form to send email to PR contact of this press release:
Retrophin Receives European Orphan Drug Designation for RE-024 for the Treatment of Pantothenate Kinase-Associated Neurodegeneration
TO: